NCT01835626 2021-05-03
Phase II Study of Radiation Therapy and Vismodegib for Advanced Head/Neck Basal Cell Carcinoma
University of California, San Francisco
Phase 2 Completed
University of California, San Francisco
National Cancer Institute (NCI)
Trans Tasman Radiation Oncology Group